• Info
  • Insider Ownership

Insider Trading & Ownership of Lori Anne Kunkel

Location
Sunnyvale, CA
Summary
The estimated net worth of Lori Anne Kunkel is at least $2,363,709 dollars as of 06 Jan 2026. Lori Anne Kunkel is the Director of CURIS INC and owns shares of CURIS INC (CRIS) stock worth about $987.7K. Lori Anne Kunkel is the Director of Enliven Therapeutics, Inc. and owns shares of Enliven Therapeutics, Inc. (ELVN) stock worth about $710.8K. Lori Anne Kunkel is the Director of Oric Pharmaceuticals, Inc. and owns shares of Oric Pharmaceuticals, Inc. (ORIC) stock worth about $665.2K.
Signature
/s/ Christian Kuhlen, attorney-in-fact
All Insider Reports
All Insider Reports

Notify me when Lori Anne Kunkel files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Lori Anne Kunkel

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
CRIS CURIS INC Director $987,700 31 Jan 2022
ELVN, IMRA Enliven Therapeutics, Inc. Director $710,829 17 Dec 2025
ORIC Oric Pharmaceuticals, Inc. Director $665,180 02 Jan 2026
NRIX Nurix Therapeutics, Inc. Director $0 19 May 2025

Insider Transactions Reported by Lori Anne Kunkel:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.